Epstein Secrets

imes.corn/2020/11/24/world/sputnik-vaccine-russia.html> (11124, Kramer, 18.61M) reports the manufacturers of the "leading Russian vaccine candidate" Sputnik V "said on Tuesday that it showed an efficacy rate of 95 percent in preliminary results from a clinical trial, which would put it at the same level

.politico.cotn/news/2020/11/24/kash-patel-pentagon-transition-440293> (11/24, Feldscher, 4.29M) reports a Pentagon spokesperson on Tuesday confirmed Kash Patel, "a White House loyalist who was installed at the Pentagon two weeks ago amid a purge of senior civilian officials, has been put in charge of the D

tgoing Trump Administration." While the New York Times (11/24, Kramer, 18.61M) reports the manufacturers of the "leading Russian vaccine candidate" Sputnik V "said on Tuesday that it showed an efficacy rate of 95 percent in preliminary results from a clinical trial, which would put it at the same level

o everything that's required by law. We'll make this work." Politico (11/24, Feldscher, 4.29M) reports a Pentagon spokesperson on Tuesday confirmed Kash Patel, "a White House loyalist who was installed at the Pentagon two weeks ago amid a purge of senior civilian officials, has been put in charge of the De

uced Batch Of Sputnik V. Reuters (5/20) reports that Brazilian pharmaceutical company Uniao Quimica "completed production of its first batch of the Sputnik V coronavirus vaccine with active ingredients and technology supplied by Russia." Russia's Gamaleya Institute "said it had seen to quality control

d William Evanina, according to three former Trump officials familiar with the episode." Politico adds, "Under the plan, the former officials said, Kash Patel - a former aide to Rep. Devin Nunes (R-Calif.) and a fierce critic of the Russia probe - would have become the bureau's deputy director." According